Monograph

S01HA02 - Oxybuprocaine

Not porphyrinogenic

Rationale

No significant metabolic load.

Chemical description

Local anaesthetic 4 mg/mL used for surface anaesthesia in ophtalmologic praxis. South African list: use (procaine)

IPNet drug reports

Uneventful use reported in 1 patient with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes S01H / S01HA or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

Monofree Oxybuprocaine · Monofree Oxybuprocaine HCl 0,4%, oogdruppels, oplossing · Obupro · Obupro 4 mg/ml oogdruppels, oplossing · Oxybuprocainehydrochloride · Minims Oxybuprocainehydrochloride 4 mg/ml, oogdruppels, oplossing

Belgium

Monofree Oxybuprocaine · Monofree Oxybuprocaine HCl 0.4 % collyre sol. récip. unidose · Oxybuprocaine Chlorhydrate · Minims Oxybuprocaine Chlorhydrate 4 mg/ml collyre sol. récip. unidose · Unicaine · Unicaine 0.4 % collyre sol. flac. compte-gouttes

United Kingdom